SKA31
CAS No. 40172-65-4
SKA31 ( SKA 31;SKA-31;Naphtho[12-d]thiazol-2-ylamine )
Catalog No. M20078 CAS No. 40172-65-4
SKA 31 is an activator of KCa3.1 and KCa2 channels (EC50s: 260 2900 2900 nM for KCa3.1 KCa2.1 and KCa2.2 respectively).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
5MG | 50 | In Stock |
|
10MG | 72 | In Stock |
|
25MG | 147 | In Stock |
|
50MG | 290 | In Stock |
|
100MG | 515 | In Stock |
|
200MG | Get Quote | In Stock |
|
500MG | Get Quote | In Stock |
|
1G | Get Quote | In Stock |
|
Biological Information
-
Product NameSKA31
-
NoteResearch use only not for human use.
-
Brief DescriptionSKA 31 is an activator of KCa3.1 and KCa2 channels (EC50s: 260 2900 2900 nM for KCa3.1 KCa2.1 and KCa2.2 respectively).
-
DescriptionSKA 31 is an activator of KCa3.1 and KCa2 channels (EC50s: 260 2900 2900 nM for KCa3.1 KCa2.1 and KCa2.2 respectively).
-
SynonymsSKA 31;SKA-31;Naphtho[12-d]thiazol-2-ylamine
-
PathwayCell Cycle/DNA Damage
-
TargetPotassium Channel
-
RecptorKCa3.1 channel
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number40172-65-4
-
Formula Weight200.26
-
Molecular FormulaC11H8N2S
-
Purity>98% (HPLC)
-
SolubilityDMSO: 30 mg/mL (150 mM)
-
SMILESNc1nc2c(ccc3ccccc23)s1
-
Chemical NameNaphtho[12-d]thiazol-2-ylamine
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Sankaranarayanan A Naphtho[12-d]thiazol-2-ylamine (SKA-31) a new activator of KCa2 and KCa3.1 potassium channels potentiates the endothelium-derived hyperpolarizing factor response and lowers blood pressure. Mol Pharmacol. 2009 Feb;75(2):281-95.
molnova catalog
related products
-
Chlorzoxazone
Chlorzoxazone is a centrally acting muscle relaxant used to treat muscle spasm and the resulting pain or discomfort.
-
BMS-813160
BMS-813160 is the first dualCCR2/CCR5antagonist to enter Clinical development for cardiovascular.
-
BMS-191011
BMS-191011 is an activator of large-conductance calcium-activated potassium (BKCa) channels effective in stroke models.